PMC:7600245 / 20182-20460 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T73","span":{"begin":93,"end":101},"obj":"Disease"},{"id":"T74","span":{"begin":104,"end":113},"obj":"Disease"},{"id":"T75","span":{"begin":246,"end":254},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The efficacy of emtricitabine and tenofovir disoproxil as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04334928)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T185","span":{"begin":58,"end":59},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T186","span":{"begin":136,"end":137},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The efficacy of emtricitabine and tenofovir disoproxil as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04334928)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T261","span":{"begin":16,"end":29},"obj":"Chemical"},{"id":"T262","span":{"begin":34,"end":54},"obj":"Chemical"},{"id":"T263","span":{"begin":34,"end":43},"obj":"Chemical"}],"attributes":[{"id":"A261","pred":"chebi_id","subj":"T261","obj":"http://purl.obolibrary.org/obo/CHEBI_31536"},{"id":"A262","pred":"chebi_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/CHEBI_63717"},{"id":"A263","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_134504"},{"id":"A264","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_63625"},{"id":"A265","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_63716"}],"text":"The efficacy of emtricitabine and tenofovir disoproxil as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04334928)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T150","span":{"begin":0,"end":278},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The efficacy of emtricitabine and tenofovir disoproxil as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04334928)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"519","span":{"begin":255,"end":263},"obj":"Species"},{"id":"536","span":{"begin":16,"end":29},"obj":"Chemical"},{"id":"537","span":{"begin":34,"end":43},"obj":"Chemical"},{"id":"538","span":{"begin":44,"end":54},"obj":"Chemical"},{"id":"540","span":{"begin":93,"end":113},"obj":"Disease"},{"id":"541","span":{"begin":246,"end":254},"obj":"Disease"}],"attributes":[{"id":"A519","pred":"tao:has_database_id","subj":"519","obj":"Tax:9606"},{"id":"A536","pred":"tao:has_database_id","subj":"536","obj":"MESH:D000068679"},{"id":"A537","pred":"tao:has_database_id","subj":"537","obj":"MESH:D000068698"},{"id":"A540","pred":"tao:has_database_id","subj":"540","obj":"MESH:C000657245"},{"id":"A541","pred":"tao:has_database_id","subj":"541","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The efficacy of emtricitabine and tenofovir disoproxil as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04334928)."}